Unknown

Dataset Information

0

PTH [1-34] induced differentiation and mineralization of mandibular condylar cartilage.


ABSTRACT: Intermittent Parathyroid Hormone (I-PTH) is the only FDA approved anabolic drug therapy available for the treatment of osteoporosis in males and postmenopausal females. The effects of I-PTH on the chondrogenic lineage of the mandibular condylar cartilage (MCC) are not well understood. To investigate the role of I-PTH on the MCC and subchondral bone, we carried out our studies using 4 to 5 week old triple transgenic mice (Col1a1XCol2a1XCol10a1). The experimental group was injected with PTH (80??g/kg) daily for 2 weeks, while control group was injected with saline. Our histology showed that the I-PTH treatment led to an increased number of cells expressing Col1a1, Col2a1 and Col10a1. Additionally, there was an increase in cellular proliferation, increased proteoglycan distribution, increased cartilage thickness, increased TRAP activity, and mineralization. Immunohistochemical staining showed increased expression of pSMAD158 and VEGF in the MCC and subchondral bone. Furthermore our microCT data showed that I-PTH treatment led to an increased bone volume fraction, tissue density and trabecular thickness, with a decrease in trabecular spacing. Morphometric measurements showed increased mandibular length and condyle head length following I-PTH treatment. In conclusion, our study suggests that I-PTH plays a critical role in cellular proliferation, proteoglycan distribution, and mineralization of the MCC.

SUBMITTER: O' Brien MH 

PROVIDER: S-EPMC5468307 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

PTH [1-34] induced differentiation and mineralization of mandibular condylar cartilage.

O' Brien Mara Heather MH   Dutra Eliane Hermes EH   Lima Alexandro A   Nanda Ravindra R   Yadav Sumit S  

Scientific reports 20170612 1


Intermittent Parathyroid Hormone (I-PTH) is the only FDA approved anabolic drug therapy available for the treatment of osteoporosis in males and postmenopausal females. The effects of I-PTH on the chondrogenic lineage of the mandibular condylar cartilage (MCC) are not well understood. To investigate the role of I-PTH on the MCC and subchondral bone, we carried out our studies using 4 to 5 week old triple transgenic mice (Col1a1XCol2a1XCol10a1). The experimental group was injected with PTH (80 μg  ...[more]

Similar Datasets

| S-EPMC8461153 | biostudies-literature
2021-08-24 | GSE162823 | GEO
| S-EPMC5056741 | biostudies-literature
| S-EPMC4011151 | biostudies-literature
| S-EPMC6914897 | biostudies-literature
| PRJNA683082 | ENA
| S-EPMC3522542 | biostudies-literature
| S-EPMC5562277 | biostudies-other
| S-EPMC8376865 | biostudies-literature
| S-EPMC6449021 | biostudies-literature